Contact Information
Company Information
Professional Summary
Kenneth Attie serves as EVP and Chief Medical Officer at Versanis Bio. Versanis Bio operates in the biotechnology sector with approximately 11.0 employees. The company is headquartered in Boston, Massachusetts. Versanis Bio generates annual revenue of 2100000.0. To date, Versanis Bio has raised 70000000.0 in total funding, with the most recent round being Series A.
Industry & Role Insights
-
•
MessageCEO tracks 381 executives in the biotechnology sector.
-
•
3,781 executive contacts are available in Massachusetts.
-
•
Our database includes 201,469 c suite-level executives.
Technologies
Outlook
Microsoft Office 365
Amazon AWS
Remote
AI
Keywords
obesity
cardiometabolic diseases
activin biology
incretin biology
transformative treatments
fat metabolism
muscle metabolism
visceral fat
clinical research
patient safety
clinical trials
medicines
insulin access programs
diabetes treatment
cancer treatment
immunology
pain management
alzheimer's disease
innovative therapies
research & development
health outcomes
drug development
gene therapy
patient support
sustainability
corporate social responsibility
cross-cultural marketing
diversity & inclusion
lilly foundation
medication safety
chronic diseases
functional cures
healthcare innovations
clinical trial access
patient assistance programs
community engagement
healthcare partnerships
quality of life improvements
pharmaceutical manufacturing
global health initiatives
diabetes management
cancer therapies
personalized medicine
neurodegenerative diseases
chronic conditions
health equity
pharmaceutical collaborations
experimental medicines
health care
health
wellness & fitness
hospital & health care
environmental services
renewables & environment
pharmaceuticals
medical
Related Executives
Outreach Guidance — biotechnology Sector
Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Kenneth Attie, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.
Kenneth Attie's Position in the MessageCEO Database
- •Kenneth Attie is 1 of 1 verified executive contact we track at Versanis Bio.
- •365 verified executive contacts in biotechnology are in the MessageCEO database.
- •3,577 verified executive contacts in Massachusetts are in the database.
- •1 verified contacts work at biotechnology companies in the 11.0 employee range (same size as Versanis Bio).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.
Frequently Asked Questions
How do I reach Kenneth Attie directly?
Kenneth Attie's verified email address is available to MessageCEO Pro subscribers. They currently serve as EVP and Chief Medical Officer at Versanis Bio. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Kenneth Attie work for?
Kenneth Attie is EVP and Chief Medical Officer at Versanis Bio, a company in the biotechnology sector with 11.0 employees. The company is based in Boston, Massachusetts.
Can I pitch or sell to Kenneth Attie?
As EVP and Chief Medical Officer at Versanis Bio, Kenneth Attie is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Kenneth Attie directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Kenneth Attie in?
Kenneth Attie works in the biotechnology industry as EVP and Chief Medical Officer at Versanis Bio. MessageCEO provides verified contact information for executives across all major industries.
Is Kenneth Attie's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Kenneth Attie's profile is kept up-to-date with the latest available information.
Last updated: June 21, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans